XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Development and License Agreements - Additional Information (Detail) - USD ($)
 1 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2020
Sep. 30, 2023
Dec. 31, 2022
BARDA Agreement        
Licenses Agreements [Line Items]        
Additional committed fund receivable     $ 3,500,000  
Committed fund receivable     185,500,000  
Reduction in committed fund receivable     8,800,000  
Committed fund receivable     270,200,000  
Receivable of billed and unbilled amounts     4,000,000.0 $ 4,000,000.0
BARDA Agreement | Cerus Corporation | Maximum        
Licenses Agreements [Line Items]        
Co-investment by the company     1,400,000  
FDA Agreement        
Licenses Agreements [Line Items]        
Contract agreement term   5 years    
Total potential contract value   $ 11,100,000    
FDA Agreement | Accounts Receivable        
Licenses Agreements [Line Items]        
Receivable of billed and unbilled amounts     300,000 200,000
DoD IBAS Agreement | Accounts Receivable        
Licenses Agreements [Line Items]        
Receivable of billed and unbilled amounts     0 500,000
DoD and IBAS Program Agreement | Other Current Assets        
Licenses Agreements [Line Items]        
Receivable of billed and unbilled amounts     $ 1,300,000 $ 100,000
DoD and IBAS Program Agreement | Maximum        
Licenses Agreements [Line Items]        
Total contract value $ 17,800,000      
DoD and IBAS Program Agreement | Minimum        
Licenses Agreements [Line Items]        
Total contract value $ 9,100,000